We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Japanese Scientists Describe Powerful Fluorescent Probe for Studying RNA

By LabMedica International staff writers
Posted on 16 Aug 2016
A team of Japanese biochemists has described the development of a powerful new fluorescent probe for studying the structure and function of double stranded RNA (dsRNA).

Investigators at Tohoku University (Sendai, Japan) created the probe by integrating the fluorescent dye thiazole orange (TO) as a base surrogate into triplex-forming PNA (peptide nucleic acid). More...
PNAs are artificially synthesized polymers similar to DNA or RNA that were invented in 1991.

DNA and RNA have a deoxyribose and ribose sugar backbone, respectively, whereas PNA's backbone is composed of repeating N-(2-aminoethyl)-glycine units linked by peptide bonds. The various purine and pyrimidine bases are linked to the backbone by a methylene bridge (-CH2-) and a carbonyl group (-(C=O)-).

The investigators reported in the July 21, 2016, online edition of the Journal of the American Chemical Society that their probe formed a thermally stable triplex with the target dsRNA at acidic pH; and the triplex formation was accompanied by the remarkable light-up response of the TO unit. The binding of the probe to the target dsRNA proceeded very rapidly, allowing real-time monitoring of the triplex formation.

The TO base surrogate in the probe functioned as a universal base for the base pair opposite the TO unit in the triplex formation. Furthermore, the TO unit was significantly more responsive towards the fully matched dsRNA sequence compared to mismatch-containing sequences, which enabled the analysis of the target dsRNA sequence at single-base pair resolution.

The probe showed a striking preference for binding to dsRNA over dsDNA, which will be important in future applications in a cellular environment where RNA and DNA co-exist.

Related Links:
Tohoku University


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.